GeneDx Holdings Corp. (WGS) NASDAQ

Currency In USD

AD

Valuation

Market Cap3.5B
Enterprise Value3.54B
P/E Ratio-24.68
PEG Ratio-0
Price/Sales Ratio4.4
Price/Book Ratio7.58
Enterprise/Revenue4.57
Enterprise/EBITDA-41.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.18
Operating Margin-0.08
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.28

Income Statement

Revenue427.54M
Revenue/Share15.09
Gross Profit298.17M
EBITDA6.63M
Net Income-21.02M
Diluted EPS-0.73

Balance Sheet

Total Cash170.69M
Total Cash/Share5.82
Total Debt168.19M
Total Debt/Equity0.66
Current Ratio3.09
Book Value Per Share8.66

Price History

52-Week Change-20.33
52-Week High170.87
52-Week Low32.21
Moving Average 50 Days54.92
Moving Average 200 Days95.16

Statistics

Average Volume1.32M
Shares Outstanding29.69M
% Held by Institutions116.22

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:33
Last Split DateMay 04, 2023
AD